https://inside.ouhsc.edu/ Parent Page: News id: 14023 Active Page: detailsid:14024

The University of Oklahoma Board of Regents approved an ambitious plan in Tulsa today to incrementally increase enrollment in the Doctor of Medicine (MD) program in the OU College of Medicine at OU Health Sciences by more than 40% over the next five years – a strategic initiative designed to address the critical demand for additional health care professionals in Oklahoma.

Read more >

Ian F. Dunn, M.D., executive dean of the University of Oklahoma College of Medicine and professor of neurosurgery, has been named a new member of the American Academy of Neurological Surgery, a premier neurosurgical professional society in North America.

Read more >

The University of Oklahoma College of Medicine is proud to announce that Jason Wagner, MD, Professor and Vice Chair of the Department of Radiological Sciences, has been elected to a five-year term on the executive board of the Society of Radiologists in Ultrasound. Wagner will begin his term as secretary in 2025, serving as treasurer in 2026, president-elect in 2027, and president of society in 2028. His term will conclude as immediate past-president in 2029.

Read more >

Recruitment is underway for a University of Oklahoma College of Medicine study that seeks to better understand the factors driving Type 2 diabetes in youth, with the aim of determining who is at highest risk for developing the disease. OU is part of a nationwide consortium funded by the National Institutes of Health to address the dramatic rise of youth diagnosed with Type 2 diabetes over the past two decades, a trend that is expected to continue.

Read more >

Patients discharged from the hospital after treatment for a major infection often continue receiving antibiotics through an IV line at home. However, medication adherence can be challenging because of a variety of barriers, and patients often find themselves readmitted to the hospital with infection-related complications. IV Ensure, an innovative remote therapeutic monitoring device being studied in a University of Oklahoma clinical trial, reduced the odds of infection-related hospital readmission by 76% at 30 days after hospital discharge and by 68% up to 90 days after discharge.

Read more >
1345678910Last